CCMG
AZN icon

Clark Capital Management Group’s AstraZeneca AZN Stock Holding History

Clark Capital Management Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118M Sell
600,052
-46,533
-7% -$8.97M 0.73% 29
2025
Q4 		$119M Sell
646,585
-657
-0.1% -$115K 0.73% 32
2025
Q3 		$99.3M Buy
647,242
+313,985
+94% +$47.5M 0.62% 40
2025
Q2 		$46.6M Buy
333,257
+137,672
+70% +$19.3M 0.32% 113
2025
Q1 		$28.8M Buy
195,585
+190,561
+3,793% +$27.6M 0.21% 133
2024
Q4 		$658K Buy
5,024
+2,369
+89% +$332K ﹤0.01% 323
2024
Q3 		$414K Sell
2,655
-67
-2% -$10.8K ﹤0.01% 341
2024
Q2 		$425K Buy
2,722
+148
+6% +$22.3K ﹤0.01% 324
2024
Q1 		$349K Sell
2,574
-214
-8% -$28.3K ﹤0.01% 347
2023
Q4 		$375K Buy
2,788
+224
+9% +$29.1K ﹤0.01% 332
2023
Q3 		$347K Sell
2,564
-74
-3% -$10.1K ﹤0.01% 303
2023
Q2 		$378K Sell
2,638
-140
-5% -$20.6K ﹤0.01% 305
2023
Q1 		$386K Sell
2,778
-165,495
-98% -$22.3M ﹤0.01% 299
2022
Q4 		$22.8M Buy
168,273
+6,065
+4% +$761K 0.21% 141
2022
Q3 		$17.8M Sell
162,208
-64,027
-28% -$8.12M 0.23% 149
2022
Q2 		$29.9M Sell
226,235
-136,776
-38% -$17.9M 0.39% 67
2022
Q1 		$48.2M Buy
363,011
+8,570
+2% +$1.03M 0.54% 40
2021
Q4 		$41.3M Sell
354,441
-291,411
-45% -$34.3M 0.51% 63
2021
Q3 		$77.6M Buy
645,852
+145,125
+29% +$16.9M 1.06% 16
2021
Q2 		$60M Buy
500,727
+183,647
+58% +$20.1M 0.84% 23
2021
Q1 		$31.5M Sell
317,080
-18,508
-6% -$1.86M 0.48% 75
2020
Q4 		$33.6M Buy
+335,588
New +$35.5M 0.55% 52

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Clark Capital Management Group's AZN Position: Q1 2026 in Review

Clark Capital Management Group reduced its AstraZeneca (AZN) stake by 7.2% in Q1 2026, selling an estimated $8.97M and leaving 600,052 shares worth $118M. The position accounts for 0.73% of the portfolio, ranked #29.

Clark Capital Management Group first reported a position in AZN in Q4 2020 and has held it in 22 quarters since. The position peaked at $119M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Clark Capital Management Group held 600,052 shares of AstraZeneca worth $118M as of Q1 2026.
  • Clark Capital Management Group sold 46,533 AstraZeneca shares in Q1 2026, an estimated $8.97M.
  • AstraZeneca made up 0.73% of Clark Capital Management Group's portfolio in Q1 2026, its #29 holding.
  • Clark Capital Management Group first reported a position in AstraZeneca in Q4 2020 and has held it in 22 quarters since.
  • Clark Capital Management Group's AstraZeneca position peaked at $119M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.